CIK in Treating Patients With Bladder Cancer
NCT02489890
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
1500
Enrollment
OTHER
Sponsor class
Conditions
Urinary Bladder Neoplasms
Interventions
BIOLOGICAL:
Cytokine-induced Killer Cells
Sponsor
The First People's Hospital of Changzhou